Top broker tips CBA (ASX:CBA) share price slide to $80

Is the CBA share price too expensive?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Commonwealth Bank of Australia (ASX: CBA) share price has been a very strong performer in 2021.

Since the start of the year, the banking giant's shares have risen a sizeable 25%.

This is more than double the return of the S&P/ASX 200 Index (ASX: XJO) over the same period.

A group of market analysts sit and stand around their computers in an open-plan office environment.

Image source: Getty Images

Where next for the CBA share price?

Unfortunately for shareholders, a number of leading brokers believe the CBA share price is overvalued and have the equivalent of sell ratings on the company.

One of the most bearish brokers is Morgans. According to a recent note, its analysts have a reduce rating and $80.00 price target on the shares of Australia's largest bank.

Based on the current CBA share price of $105.10, this suggests there's potential downside of almost 24% over the next 12 months.

What is being said?

The note reveals that Morgans believes CBA is a quality bank, it just feels its shares are overvalued at the current level.

The broker has previously stated: "While we continue to believe that CBA has a relatively high quality retail franchise and a relatively good risk profile, we continue to believe that CBA is expensive relative to the other major banks."

Elsewhere, earlier this month the team at Morgan Stanley retained their underweight and $90.00 price target on the bank's shares.

Its analysts note that CBA has significant exposure to housing loans. In fact, it estimates that approximately 60% of its total loan balance relate to home loans.

In light of this, home loan approvals are a key driver of loan growth for the bank. So, with APRA recently increasing bank loan serviceability expectations, it fears this could weigh on CBA's performance if it leads to lower home loan approvals.

Investors may not have to wait long to find out if this is the case. The banking giant is scheduled to release its first quarter results in the middle of next month. All eyes will be on the CBA share price that day.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: What this leading broker is saying about Lynas shares

Is it bullish or bearish? Let's find out.

Read more »

share buyers, investors, happy investors
Broker Notes

Bell Potter's top ASX 200 holdings revealed

These are the top holdings in the broker's core portfolio.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Broker Notes

Up 139% in a year, why this buy rated ASX All Ords rare earths stock could keep racing higher

A leading broker forecasts more outperformance to come from this surging ASX rare earths stock.

Read more »

Miner with thumbs up at a mine.
Gold

2 ASX gold miners to buy for solid share price gains, according to Barrenjoey

The Africa-focused companies are deeply undervalued after recent sell-offs, the broker says.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »